Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study.

导出 OA

翻译打印收藏纠错

第一作者： Alicia Milagros,de Luna Aguilar

第一单位： Department of Medical Oncology, Hospital Clinico San Carlos, IdISSC, Calle Profesor Martín Lagos, S/N, 28040 Madrid, Spain.

作者： Alicia Milagros,de Luna Aguilar ^[1] ; Javier David Benitez,Fuentes ^[2] ; Justo,Ortega Anselmi ^[1] ; Jennifer,Olalla Inoa ^[2] ; Paloma,Flores Navarro ^[1] ; Alfonso,Lopez de Sá ^[1] ; Jesus,Fuentes Antras ^[1] ; Cristina,Rodríguez Rey ^[1] ; Aída,Ortega Candil ^[1] ; Fernando,Moreno Antón ^[3] ; Jose Ángel,García Sáenz ^[3]

作者单位： Department of Medical Oncology, Hospital Clinico San Carlos, IdISSC, Calle Profesor Martín Lagos, S/N, 28040 Madrid, Spain. ^[1] Velindre Cancer Centre, Velindre University NHS Trust, Cardiff CF14 2TL, UK. ^[2] Department of Nuclear Medicine, Hospital Clinico San Carlos, IdISSC, Calle Profesor Martín Lagos, S/N, 28040 Madrid, Spain. ^[3]

关键词 abemaciclib continuing CDK4/6 inhibition endocrine therapy metastatic breast cancer rechallenge

DOI 10.3390/cancers15184452

PMID 37760421

发布时间 2023-10-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交